Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Bostwick

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasiaKyung Park, James T Dalton, Ramesh Narayanan, et al.
Dose-Response : a Publication of International Hormesis Society|September 30, 2010
Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and ApoptosisEmily C Chiang, Shuren Shen, Seema S Kengeri, et al.
Journal of Endourology|December 20, 2002
Laparoscopic partial nephrectomy with a novel electrosurgical snare in a porcine modelWilliam C Collyer, Jaime Landman, Ephrem O Olweny, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 29, 2006
Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostateXiaoyan Wang, Timothy D Jones, Shaobo Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Cancer|October 21, 2004
Human prostate cancer risk factorsDavid G Bostwick, Harry B Burke, Daniel Djakiew, et al.
Journal of the National Cancer Institute|February 6, 2003
Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostateDavid J Waters, Shuren Shen, Dawn M Cooley, et al.
Urology|October 20, 2004
Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissueLeonard S Marks, Munekado Kojima, Angelo Demarzo, et al.
Urology|June 12, 2014
Modeling and analysis of Gleason score 8-10 prostate cancers in the REDUCE studyGerald L Andriole, David G Bostwick, Leonard G Gomella, et al.
The Prostate|August 9, 2007
Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancerGirish Venkataraman, Georg Heinze, Earle W Holmes, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasiaKyung Park, James T Dalton, Ramesh Narayanan, et al.
Dose-Response : a Publication of International Hormesis Society|September 30, 2010
Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and ApoptosisEmily C Chiang, Shuren Shen, Seema S Kengeri, et al.
Journal of Endourology|December 20, 2002
Laparoscopic partial nephrectomy with a novel electrosurgical snare in a porcine modelWilliam C Collyer, Jaime Landman, Ephrem O Olweny, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 29, 2006
Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostateXiaoyan Wang, Timothy D Jones, Shaobo Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Cancer|October 21, 2004
Human prostate cancer risk factorsDavid G Bostwick, Harry B Burke, Daniel Djakiew, et al.
Journal of the National Cancer Institute|February 6, 2003
Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostateDavid J Waters, Shuren Shen, Dawn M Cooley, et al.
Urology|October 20, 2004
Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissueLeonard S Marks, Munekado Kojima, Angelo Demarzo, et al.
Urology|June 12, 2014
Modeling and analysis of Gleason score 8-10 prostate cancers in the REDUCE studyGerald L Andriole, David G Bostwick, Leonard G Gomella, et al.
The Prostate|August 9, 2007
Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancerGirish Venkataraman, Georg Heinze, Earle W Holmes, et al.
Pageof 12